Mohy El-Din Ismail, an Egyptian pharmacist founded Insight in 2018 with the mission of revolutionizing patient safety in Egypt.

Through his dedication and innovative approach, Mohy introduced advanced pharmacovigilance and safety solutions to the Egyptian market, positioning Insight as the industry leader in this critical field.

Before founding Insight, Mohy worked at the Egyptian Drug Authority (EDA) as a Regulatory Compliance Officer, where he oversaw the registration and licensing of pharmaceutical products and served as a member of the Medical Scientific Committee. His experience also includes operations management at the Minister’s Office of Health and Population in Egypt.

In addition to leading Insight, Mohy has served as a compliance and pharmacovigilance consultant for various national and international companies. He also led the Vigipx Safety Database, a cutting-edge software for processing ICSRs and performing quantitative analysis of safety data in line with the world’s highest safety and technical standards. Today, Vigipx is recognized as Egypt’s number one safety database.

Mohy’s career reflects a commitment to innovation and dedication to enhancing patient safety systems. His profound impact on the industry continues to shape the future of drug safety in the region.